Novartis, UPenn & Tumors: Fishman Explains
Linkedin

Novartis, UPenn & Tumors: Fishman Explains

Philadelphia : PA : USA | Aug 07, 2012 at 7:14 AM PDT
Source: Pharmalot
XX XX
Views: Pending
 
Earlier this week, Novartis and the University of Pennsylvania announced a research and licensing agreement to develop treatments that can activate a patient's own immune system to fight cancerous tumors. The collaboration is based around targeted chimeric antigen receptor (CAR) immunotherapies.... FULL ARTICLE AT Pharmalot
 
  • Clear
  • Share:
  • Share
  • Clear
  • Clear
  • Clear
  • Clear
 
  • Credibility
  • Wait... Flag
 
 
Advertisement
 

More From Allvoices



Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc. 2008-2014. All rights reserved. Powered by PulsePoint.